EOLS
Evolus, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares -10.6% ·
flujo de acciones -18.3% ·
nuevas posiciones netas -11.9%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2026
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 651.82K | $5.21M | n/a | n/a |
| Q2 2026 | 63 | +6 | 23.25M | $161.16M | +10 | −4 |
| Q1 2026 | 59 | -7 | 18.93M | $77.97M | +3 | −10 |
| Q4 2025 | 66 | -1 | 24.04M | $159.85M | n/a | −1 |
| Q3 2025 | 17 | -1 | 17.27M | $106.03M | n/a | −1 |
| Q2 2025 | 15 | 0 | 14.12M | $130.04M | +1 | −1 |
| Q1 2025 | 12 | +2 | 7.19M | $86.49M | +2 | n/a |
| Q4 2024 | 10 | -1 | 6.42M | $70.90M | n/a | −1 |
| Q3 2024 | 10 | 0 | 4.64M | $75.21M | +1 | −1 |
| Q2 2024 | 10 | n/a | 4.38M | $47.51M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.32M | -16.1% | $5.43M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 2 | Goldman Sachs Group ✦ | 1.09M | +209.7% | $4.47M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Charles Schwab Investment… | 515.52K | -0.3% | $2.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Northern Trust Corp | 472.34K | +6.1% | $1.94M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 5 | Stifel Financial Corp | 458.40K | +74.2% | $1.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 6 | Deutsche Bank Ag\ | 441.65K | +1.1% | $1.82M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 240.13K | -67.1% | $986,947 | 0.0% | ▼ Trim | 3 | SEC ↗ ×7 |
| 8 | Bank Of America Corp /De/ | 155.25K | -56.6% | $638,069 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 9 | State Of Wisconsin Investment Board | 98.28K | +51.0% | $403,951 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 97.96K | +14.8% | $403,000 | 0.0% | ▲ Add | 8 | SEC ↗ |
| 11 | Wells Fargo & Company/Mn | 74.50K | -1.9% | $306,183 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 12 | Invesco Ltd. | 36.34K | +6.5% | $149,336 | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 13 | Hsbc Holdings Plc | 34.29K | Nuevo | $142,467 | 0.0% | New | 1 | SEC ↗ |
| 14 | Ameriprise Financial Inc | 30.64K | -43.5% | $125,910 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 15 | JPMorgan Chase ✦ | 31.48K | -86.0% | $124,015 | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 16 | Barclays Plc | 27.88K | -78.7% | $114,578 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 17 | Sei Investments Co | 25.95K | -43.0% | $106,660 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 18 | Manufacturers Life Insurance… | 16.22K | -0.1% | $66,660 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | New York State Common Retirement… | 14.15K | 0.0% | $58,173 | 0.0% | Held | 2 | SEC ↗ |
| 20 | State Board Of Administration Of… | 11.86K | 0.0% | $48,740 | 0.0% | Held | 2 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 8.88K | +181.5% | $36,503 | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 22 | Citigroup Inc | 6.41K | -81.9% | $26,328 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 23 | Legal & General Group Plc | 4.68K | -14.2% | $19,243 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Pnc Financial Services Group, Inc. | 1.74K | +323.1% | $7,164 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Jones Financial Companies Lllp | 390 | 0.0% | $1,564 | 0.0% | Held | 2 | SEC ↗ |
| 26 | Royal Bank Of Canada | 394 | -88.4% | $1,000 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Hsbc Holdings Plc | $142,467 | 0.0% |
Posición cerrada
| Wellington Management | $1.30M | era 0.0% |
| Mercer Global Advisors Inc… | $144,046 | era 0.0% |
| Us Bancorp \De\ | $559 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 146 tenedores, 45.63M acciones, $187.01M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 105.11K acc. · $950,019
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología